⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL251529 | 0.70 | — | — | |
| SCHEMBL2050206 | 0.70 | — | — | |
| SCHEMBL8735005 | 0.70 | — | — | |
| Hydrochloric Acid SCHEMBL9283661 | 0.67 | — | — | |
| SCHEMBL11089429 | 0.65 | — | — | |
| SCHEMBL19435073 | 0.65 | — | — | |
| SCHEMBL22592188 | 0.65 | — | — | |
| SCHEMBL9511373 | 0.63 | — | — | |
| SCHEMBL10749250 | 0.62 | — | — | |
| SCHEMBL678068 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240116843-A1 | PROCESS FOR THE PREPARATION OF VITAMIN K2 AND NOVEL INTERMEDIATES | KAPP A BIOSCIENCE AS (NO) | 2024-04-11 | — | — | US | disclosed |
| US-11912654-B2 | Process for stereospecific synthesis of vitamin K2 and its novel intermediates | SYNERGIA LIFE SCIENCES PVT. LTD. (IN) | 2024-02-27 | — | — | US | disclosed |
| EP-4301721-A1 | PROCESS FOR THE PREPARATION OF VITAMIN K2 AND NOVEL INTERMEDIATES | Kappa Bioscience AS (NO) | 2024-01-10 | — | — | EP | disclosed |
| US-20230093176-A1 | PROCESS FOR STEREOSPECIFIC SYNTHESIS OF VITAMIN K2 AND ITS NOVEL INTERMEDIATES | SYNERGIA LIFE SCIENCES PVT. LTD. (IN) | 2023-03-23 | — | — | US | disclosed |
| WO-2023031841-A1 | A PROCESS FOR THE STEREOSPECIFIC SYNTHESIS OF VITAMIN K2 AND ITS INTERMEDIATES | SYNERGIA LIFE SCIENCES PVT. LTD. (IN) | 2023-03-09 | — | — | WO | disclosed |
| US-11090276-B2 | Formulation of fat-soluble vitamin | BASF SE (DE) | 2021-08-17 | — | — | US | disclosed |
| EP-3139904-B1 | FORMULATION OF FAT-SOLUBLE VITAMIN | BASF SE (DE) | 2021-03-03 | — | — | EP | disclosed |
| EP-3018116-B1 | VITAMIN K2 INTERMEDIATES | KAPPA BIOSCIENCE AS (NO) | 2020-10-28 | — | — | EP | disclosed |
| US-10472314-B2 | Process for the preparation of vitamin K2 | KAPPA BIOSCIENCE AS (NO) | 2019-11-12 | — | — | US | disclosed |
| US-10159687-B2 | Prodrugs of vitamin K | KAPPA BIOSCIENCE AS (NO) | 2018-12-25 | — | — | US | disclosed |
| CN-104395273-A | Prodrugs of Vitamin K | KAPPA BIOSCIENCE AS | 2015-03-04 | — | — | CN | disclosed |
| WO-2015018858-A1 | COMPOSITIONS COMPRISING VITAMIN K DERIVATIVES AND SALTS | KAPPA BIOSCIENCE AS (NO) | 2015-02-12 | — | — | WO | disclosed |
| US-20150031651-A1 | PRODRUGS OF VITAMINE K | KAPPA BIOSCIENCE AS (NO) | 2015-01-29 | — | — | US | disclosed |
| EP-2819982-A1 | PRODRUGS OF VITAMINE K | Kappa Bioscience AS (NO) | 2015-01-07 | — | — | EP | disclosed |
| WO-2013128037-A1 | PRODRUGS OF VITAMINE K | KAPPA BIOSCIENCE AS (NO) | 2013-09-06 | — | — | WO | disclosed |
| WO-2011117324-A2 | PROCESS FOR THE PREPARATION OF VITAMIN K2 | KAPPA BIOSCIENCE AS (NO) | 2011-09-29 | — | — | WO | disclosed |
| US-20110207967-A1 | PROCESS FOR THE PREPARATION OF VITAMIN K2 | KAPPA BIOSCIENCE AS (NO) | 2011-08-25 | — | — | US | disclosed |
| EP-2346806-A1 | PROCESS FOR THE PREPARATION OF VITAMIN K2 | Kappa Bioscience As (NO) | 2011-07-27 | — | — | EP | disclosed |
| WO-2010034999-A1 | CRYSTALLINE MENOQUINONE-7 (VITAMIN K2) | KAPPA BIOSCIENCE AS (NO) | 2010-04-01 | — | — | WO | disclosed |
| WO-2010035000-A1 | PROCESS FOR THE PREPARATION OF VITAMIN K2 | KAPPA BIOSCIENCE AS (NO) | 2010-04-01 | — | — | WO | disclosed |